Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubing Shi

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Nature Biomedical Engineering|April 13, 2019
Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumoursHan Yao, Jiang Lan, Chushu Li, et al.
Nature Biomedical Engineering|April 7, 2019
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumoursHan Yao, Jiang Lan, Chushu Li, et al.
Nature Methods|March 5, 2024
Real-time detection of 20 amino acids and discrimination of pathologically relevant peptides with functionalized nanoporeMing Zhang, Chao Tang, Zichun Wang, et al.
Signal Transduction and Targeted Therapy|June 8, 2025
Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic ductal adenocarcinoma metastasisXiaowei Liu, Jinen Song, Meiling Yuan, et al.
Cancer Cell|January 27, 2023
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillanceXiaowei Liu, Jinen Song, Hao Zhang, et al.
The Journal of Investigative Dermatology|August 6, 2021
The Evolution of Acquired Resistance to BRAF<sup>V600E</sup> kinase inhibitor Is Sustained by IGF1-Driven Tumor Vascular RemodelingGuangchao Xu, Ya Luo, Wenshuang Wu, et al.
Biomaterials|April 26, 2026
Physiological respiration pressure-driven piezocatalytic therapy for malignant ascites with a gold-core magnified mesoporous piezoelectric nanoplatformYujie Zhao, Zihan Xu, Linkai Tang, et al.
Cancer Discovery|November 23, 2013
A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibitionHubing Shi, Aayoung Hong, Xiangju Kong, et al.
Cell Discovery|September 21, 2016
JUN dependency in distinct early and late BRAF inhibition adaptation states of melanomaBjoern Titz, Anastasia Lomova, Allison Le, et al.
Nature|November 26, 2010
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationRamin Nazarian, Hubing Shi, Qi Wang, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Nature Biomedical Engineering|April 13, 2019
Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumoursHan Yao, Jiang Lan, Chushu Li, et al.
Nature Biomedical Engineering|April 7, 2019
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumoursHan Yao, Jiang Lan, Chushu Li, et al.
Nature Methods|March 5, 2024
Real-time detection of 20 amino acids and discrimination of pathologically relevant peptides with functionalized nanoporeMing Zhang, Chao Tang, Zichun Wang, et al.
Signal Transduction and Targeted Therapy|June 8, 2025
Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic ductal adenocarcinoma metastasisXiaowei Liu, Jinen Song, Meiling Yuan, et al.
Cancer Cell|January 27, 2023
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillanceXiaowei Liu, Jinen Song, Hao Zhang, et al.
The Journal of Investigative Dermatology|August 6, 2021
The Evolution of Acquired Resistance to BRAF<sup>V600E</sup> kinase inhibitor Is Sustained by IGF1-Driven Tumor Vascular RemodelingGuangchao Xu, Ya Luo, Wenshuang Wu, et al.
Biomaterials|April 26, 2026
Physiological respiration pressure-driven piezocatalytic therapy for malignant ascites with a gold-core magnified mesoporous piezoelectric nanoplatformYujie Zhao, Zihan Xu, Linkai Tang, et al.
Cancer Discovery|November 23, 2013
A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibitionHubing Shi, Aayoung Hong, Xiangju Kong, et al.
Cell Discovery|September 21, 2016
JUN dependency in distinct early and late BRAF inhibition adaptation states of melanomaBjoern Titz, Anastasia Lomova, Allison Le, et al.
Nature|November 26, 2010
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationRamin Nazarian, Hubing Shi, Qi Wang, et al.
Pageof 9